Quality Assessment: Strong Operational and Financial Metrics
Apollo Hospitals continues to demonstrate exceptional quality in its operations and financial health. The company boasts a high Return on Capital Employed (ROCE) of 16.84%, underscoring efficient capital utilisation and strong management effectiveness. This figure is particularly notable given the hospital sector’s capital-intensive nature. Additionally, Apollo has maintained positive results for nine consecutive quarters, with the latest quarter (Q3 FY25-26) recording its highest-ever net sales of ₹6,477.40 crores and a PBDIT of ₹965.30 crores.
The company’s debt servicing capability remains robust, with a low Debt to EBITDA ratio of 2.40 times, indicating manageable leverage and financial stability. This prudent capital structure supports sustainable growth and reduces risk exposure. Furthermore, Apollo’s net sales have grown at an annualised rate of 17.93%, while operating profit margins have expanded to 39.35%, reflecting operational efficiency and strong demand for healthcare services.
MarketsMojo’s quality grading places Apollo Hospitals among the top 1% of over 4,000 stocks analysed, highlighting its superior fundamentals relative to peers. This high-quality profile is a key factor in the upgrade to a Buy rating.
Valuation: Attractive Relative to Peers and Historical Levels
Despite its large-cap status with a market capitalisation of ₹1,16,250 crores, Apollo Hospitals is trading at a discount compared to its peers’ average historical valuations. The company’s Enterprise Value to Capital Employed ratio stands at a fair 8.7, suggesting reasonable pricing relative to the capital invested in the business.
Over the past year, Apollo’s stock has delivered a 20.25% return, outperforming the BSE Sensex, which declined by 4.33% over the same period. This outperformance is supported by a 38.7% rise in profits, resulting in a PEG ratio of 1.7. Such metrics indicate that the stock offers growth potential at a fair valuation, making it an attractive proposition for investors seeking value within the healthcare sector.
Moreover, Apollo’s annual sales of ₹24,215.20 crores represent 28.32% of the hospital industry’s total, reinforcing its dominant market position and pricing power. The company also constitutes 19.27% of the sector’s market capitalisation, underscoring its leadership role.
Handpicked from 50, scrutinized by experts – Our recent selection, this Mid Cap from Bank - Public, is already delivering results. Don't miss next month's pick!
- - Expert-scrutinized selection
- - Already delivering results
- - Monthly focused approach
Financial Trend: Consistent Growth and Profitability
The financial trajectory of Apollo Hospitals remains strongly positive. The company has consistently reported growth in net sales and profitability, with the latest half-year ROCE at 16.11% and quarterly PBDIT reaching a record ₹965.30 crores. This sustained performance is a testament to effective management strategies and operational excellence.
Annualised net sales growth of 17.93% and operating profit growth of 39.35% highlight the company’s ability to expand its revenue base while improving margins. The positive results over nine consecutive quarters further reinforce the stability and upward momentum in financial performance.
Institutional investors hold a significant 65.61% stake in Apollo Hospitals, reflecting strong confidence from sophisticated market participants who typically conduct rigorous fundamental analysis before committing capital. This high institutional ownership adds a layer of credibility and support to the stock’s outlook.
Technical Analysis: Upgrade to Bullish Signals
The recent upgrade in Apollo Hospitals’ investment rating is also driven by a marked improvement in technical indicators. The technical grade has shifted from mildly bullish to bullish, signalling stronger momentum in the stock price.
Key technical metrics include a bullish Moving Average on the daily chart and a weekly MACD that remains positive, although the monthly MACD is mildly bearish. Bollinger Bands indicate a mildly bullish trend on the weekly timeframe and a bullish trend monthly, suggesting increasing volatility in favour of upward price movement.
Other indicators such as the KST (Know Sure Thing) and Dow Theory are bullish on the weekly scale, with monthly readings mildly bearish but not detracting from the overall positive trend. The Relative Strength Index (RSI) shows no significant signals, indicating the stock is not currently overbought or oversold.
Price action remains strong, with the stock trading near its 52-week high of ₹8,143.25, and daily price fluctuations between ₹8,026.75 and ₹8,143.25 on the latest trading day. Despite a minor day change of -0.17%, the stock’s longer-term technical outlook supports the upgrade.
Market Performance: Outperforming Benchmarks
Apollo Hospitals has delivered market-beating returns over multiple time horizons. The stock’s 1-week return of 4.43% contrasts sharply with the Sensex’s decline of 1.62%. Over one month, Apollo gained 7.54% while the Sensex fell 1.98%. Year-to-date, the stock has surged 14.74%, outperforming the Sensex’s negative 10.80% return.
Longer-term performance is even more impressive, with 3-year returns of 75.96% versus the Sensex’s 22.79%, 5-year returns of 147.94% compared to 54.62%, and a remarkable 10-year return of 512.52% against the Sensex’s 196.97%. These figures underscore Apollo’s consistent ability to generate superior shareholder value over time.
Curious about Apollo Hospitals Enterprise Ltd. from Hospital? Get the complete picture with our detailed research report covering fundamentals, technicals, peer analysis, and everything you need to decide!
- - Detailed research coverage
- - Technical + fundamental view
- - Decision-ready insights
Conclusion: A Compelling Buy in the Hospital Sector
The upgrade of Apollo Hospitals Enterprise Ltd. from Hold to Buy by MarketsMojo reflects a comprehensive improvement across multiple investment parameters. The company’s strong quality metrics, including high ROCE and consistent profitability, combined with attractive valuation relative to peers, underpin its fundamental appeal.
Financial trends remain robust with sustained growth in sales and profits, supported by prudent debt management and high institutional ownership. Technical indicators have turned decisively bullish, signalling positive momentum in the stock price. Apollo’s market-beating returns over short and long-term periods further validate its investment case.
As the largest player in the hospital sector with a commanding market share and industry-leading sales, Apollo Hospitals is well positioned to capitalise on the growing demand for healthcare services in India. Investors seeking exposure to a high-quality, well-valued, and technically supported stock in the healthcare space should consider Apollo Hospitals as a compelling Buy opportunity.
Get Started for only Rs. 16,999 - Get MojoOne for 2 Years + 1 Year Absolutely FREE! (72% Off) Start Today
